The NIH Chooses Unisys - Analyst Blog

By
A A A

Last week, Unisys Corporation ( UIS ) received a contract from The National Institutes of Health (NIH) to compete with another 53 companies for task orders. This contract was awarded by The NIH under the Chief Information Officers-Solutions and Partners 3 (CIO-SP3) contract vehicle.

This indefinite delivery/indefinite quantity (IDIQ) contract awarded to the 54 companies including Unisys is expected to be worth $20 billion over a period of 10 years. The ten categories of task orders Unisys can compete for include federal health mission IT support services, federal CIO office IT support services, services for supporting collection etc.

The CIO-SP3 deal was not the first award offered by The NIH to Unisys. Its previous CIO-SP3 agreement expired recently. Hence, the present superseding CIO-SP3 contract avers that The NIH affirms a lot of faith and confidence in Unisys' solutions through such long-term ventures.   

Such continual contract wins have become a major growth driver for boosting sales incipiently for the company. On April 24, 2012, Unisys declared financial results of its first quarter in 2012, whereby total revenue surged almost 2% annually to reach $928.4 million. We believe that the company needs these major panegyrics in the form of contract wins and extensions in order to post even stronger results in its upcoming quarters.

Unisys should also keep a wary eye out for competitor advances in the industry. Big players in this regard include EPAM Systems, Inc. ( EPAM ), CoStar Group Inc. ( CSGP ) and Fair Issac Corp. ( FICO ).  

The company currently retains a Zacks #3 Rank, which translates into a short-term 'Hold' rating. However, we presently maintain our 'Neutral' recommendation on the stock.


 
COSTAR GRP INC (CSGP): Free Stock Analysis Report
 
EPAM SYSTEMS (EPAM): Free Stock Analysis Report
 
FAIR ISAAC INC (FICO): Free Stock Analysis Report
 
UNISYS (UIS): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: CSGP , EPAM , FICO , UIS

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

242,336,698
    $91.30 unch
198,176,479
  • $40.9124 ▼ 2.79%
73,992,503
  • $5.353 ▼ 1.05%
69,677,534
  • $16.975 ▼ 0.38%
54,172,694
  • $39.88 ▼ 4.02%
48,488,165
  • $47.03 ▲ 0.75%
46,398,206
  • $101.9567 ▲ 0.16%
37,771,837
  • $3.60 ▼ 0.96%
As of 9/19/2014, 03:08 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com